Active Ingredient (In Each Tablet)
Pseudoephedrine HCl USP, 120 mg
The following Structured Product Label (SPL) was submitted to the FDA by Chain Drug Marketing Association Inc. for the product Pseudoephedrine Hydrochloride (NDC 63868-143). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Pseudoephedrine HCl USP, 120 mg
Nasal decongestant
Temporarily relieves nasal congestion due to:
If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
Castor oil, colloidal silicon dioxide, hypromellose, microcrystalline cellulose, magnesium stearate, titanium dioxide
Call 1-800-406-7984
QC QUALITY CHOICE®
NDC 63868-0143-10
*Compare to the active ingredient in SUDAFED®12 Hour
NON-DROWSY
12 Hour
Suphedrine
Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, USP
Long-Acting Nasal Decongestant Tablets
10 Coated Capsule-Shaped Tablets
120 mg Each
©DISTRIBUTED BY QUALITY CHOICE
5089414 R0911
* Please review the disclaimer below.